Get the Stockscreener App
1.22
1.67%
0.02
After Hours:
1.21
-0.01
-0.82%
Lucid Diagnostics Inc stock is traded at $1.22, with a volume of 586.11K.
It is up +1.67% in the last 24 hours and up +2.52% over the past month.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
See More
Previous Close:
$1.20
Open:
$1.19
24h Volume:
586.11K
Relative Volume:
0.47
Market Cap:
$159.94M
Revenue:
$4.35M
Net Income/Loss:
$-45.53M
P/E Ratio:
-1.1296
EPS:
-1.08
Net Cash Flow:
$-44.79M
1W Performance:
+6.09%
1M Performance:
+2.52%
6M Performance:
+22.31%
1Y Performance:
-8.27%
1-Day Range:
$1.18
$1.23
1-Week Range:
$1.15
$1.24
52-Week Range:
$0.9495
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Name
Lucid Diagnostics Inc
Sector
Industry
Phone
212 949 4319
Address
360 MADISON AVENUE, NEW YORK
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.22 | 157.32M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-21 | Initiated | Ascendiant Capital Markets | Buy |
| Nov-08-21 | Initiated | BTIG Research | Buy |
| Nov-08-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-08-21 | Initiated | Needham | Buy |
Lucid Diagnostics Inc Stock (LUCD) Latest News
Earnings Miss: Is Lucid Diagnostics Inc showing insider buying2025 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed wipes out legacy convertibles in $45M balance-sheet reset - Stock Titan
Stock Analysis: What is Lucid Diagnostics Incs valuation compared to sector2025 Growth vs Value & Daily Chart Pattern Signals - baoquankhu1.vn
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Down 20.0% in January - MarketBeat
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Is Lucid Diagnostics Inc. gaining market share2025 Technical Overview & Fast Exit and Entry Strategy Plans - mfd.ru
Revenue Check: Is Corvus Pharmaceuticals Inc a stock for growth or value investorsWeekly Profit Summary & AI Based Buy and Sell Signals - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD) - Seeking Alpha
Perkins Capital Management Inc. Invests $1.14 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
PAVmed subsidiary Lucid Diagnostics spikes on Veterans Affairs contract - MSN
Individual investors among Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest stockholders and were hit after last week's 14% price drop - simplywall.st
Retail Surge: Can Lucid Diagnostics Inc expand into new markets2025 Institutional Moves & Stock Timing and Entry Methods - baoquankhu1.vn
Aug Summary: Can Lucid Diagnostics Inc expand into new marketsMarket Growth Review & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
What's Going On With PAVmed Shares Thursday? - Benzinga
Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - MEXC
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares - TechStock²
Lucid Diagnostics secures VA contract for esophageal cancer test By Investing.com - Investing.com Nigeria
Lucid Diagnostics Inc. (LUCD) stock: slides after early spike despite major VA contract win - parameter.io
PAVmed Inc. Stock (PAVM) Opinions on VA Contract Win - Quiver Quantitative
PAVM Stock Shot Up Over 250% Today – What’s The Deal With The Department of Veterans Affairs? - Stocktwits
Why Is PAVmed Stock Skyrocketing Wednesday? - Benzinga
PAVM stock shot up over 250% today – what’s the deal with the Department of Veterans Affairs? - MSN
Lucid Diagnostics Wins U.S. Department of Veterans Affairs Contract for EsoGuard - marketscreener.com
Lucid Diagnostics stock surges after securing VA contract for cancer test - Investing.com Australia
Lucid Diagnostics stock surges after securing VA contract for cancer test By Investing.com - Investing.com South Africa
PAVmed-unit Lucid Diagnostics spikes on VA contract (LUCD) - Seeking Alpha
Lucid Diagnostics rises after winning VA contract for cancer test - TradingView
Lucid Diagnostics secures VA contract for esophageal cancer test - Investing.com
Aug Gainers: Is Lucid Diagnostics Inc stock a top performer YTD2025 Market Trends & Low Risk Growth Stock Ideas - baoquankhu1.vn
Forecast Cut: Is Lucid Diagnostics Inc gaining market share2025 Earnings Impact & Real-Time Volume Analysis - baoquankhu1.vn
Why Lucid Diagnostics Inc. stock remains on buy listsWeekly Risk Report & Consistent Profit Trade Alerts - ulpravda.ru
Lucid Diagnostics Insider Ups Holding By 162% During Year - Yahoo Finance UK
How analysts rate Lucid Diagnostics Inc. stock todayShare Buyback & Consistent Profit Alerts - ulpravda.ru
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Lucid Diagnostics (NASDAQ:LUCD) Stock Price Up 0.9% – Here’s Why - Defense World
Lucid Diagnostics (NASDAQ:LUCD) Stock Price Up 0.9%Here's Why - MarketBeat
Lucid Diagnostics Inc Stock (LUCD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):